- Home
- ATLCP vs FBIOP Comparison
ATLCP vs FBIOP Comparison
Compare ATLCP & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLCP
- FBIOP
- Stock Information
- Founded
- ATLCP N/A
- FBIOP N/A
- Country
- ATLCP United States
- FBIOP United States
- Employees
- ATLCP 417
- FBIOP 101
- Industry
- ATLCP Finance: Consumer Services
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- ATLCP Finance
- FBIOP Health Care
- Exchange
- ATLCP Nasdaq
- FBIOP Nasdaq
- Market Cap
- ATLCP N/A
- FBIOP N/A
- IPO Year
- ATLCP N/A
- FBIOP N/A
- Fundamental
- Price
- ATLCP $22.05
- FBIOP $7.49
- Analyst Decision
- ATLCP
- FBIOP
- Analyst Count
- ATLCP 0
- FBIOP 0
- Target Price
- ATLCP N/A
- FBIOP N/A
- AVG Volume (30 Days)
- ATLCP N/A
- FBIOP N/A
- Earning Date
- ATLCP N/A
- FBIOP N/A
- Dividend Yield
- ATLCP N/A
- FBIOP N/A
- EPS Growth
- ATLCP N/A
- FBIOP N/A
- EPS
- ATLCP N/A
- FBIOP N/A
- Revenue
- ATLCP N/A
- FBIOP N/A
- Revenue This Year
- ATLCP N/A
- FBIOP N/A
- Revenue Next Year
- ATLCP N/A
- FBIOP N/A
- P/E Ratio
- ATLCP N/A
- FBIOP N/A
- Revenue Growth
- ATLCP N/A
- FBIOP N/A
- 52 Week Low
- ATLCP N/A
- FBIOP N/A
- 52 Week High
- ATLCP N/A
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- ATLCP 32.40
- FBIOP 42.14
- Support Level
- ATLCP $22.01
- FBIOP $7.45
- Resistance Level
- ATLCP $22.20
- FBIOP $8.40
- Average True Range (ATR)
- ATLCP 0.11
- FBIOP 0.56
- MACD
- ATLCP 0.01
- FBIOP -0.19
- Stochastic Oscillator
- ATLCP 13.33
- FBIOP 13.86
About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.